Intelligent Historical Income Statement
| INBS Stock | USD 1.64 0.04 2.50% |
Historical analysis of Intelligent Bio income statement accounts such as Selling General Administrative of 4.9 M or Other Operating Expenses of 8.3 M can show how well Intelligent Bio Solutions performed in making a profits. Evaluating Intelligent Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Intelligent Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Intelligent Bio Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intelligent Bio Solutions is a good buy for the upcoming year.
Intelligent |
About Intelligent Income Statement Analysis
Intelligent Bio Solutions Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Intelligent Bio shareholders. The income statement also shows Intelligent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Intelligent Bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Intelligent Bio Solutions. It is also known as Intelligent Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Intelligent Bio Solutions operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Intelligent Bio Solutions is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Total Revenue
Total revenue comprises all receipts Intelligent Bio Solutions generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from Intelligent Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, Intelligent Bio's Depreciation And Amortization is comparatively stable compared to the past year. Research Development is likely to gain to about 1.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.9 M in 2024.
| 2021 | 2023 | 2024 (projected) | Interest Expense | 7.5K | 167.1K | 158.8K | Depreciation And Amortization | 966.7K | 1.2M | 1.4M |
Intelligent Bio income statement Correlations
Click cells to compare fundamentals
Intelligent Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intelligent Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 57.9K | 151.0K | 5.2M | 966.7K | 1.2M | 1.4M | |
| Interest Expense | 457.7K | 1.1M | 7.5K | 223.5K | 167.1K | 158.8K | |
| Selling General Administrative | 3.5M | 2.4M | 3.7M | 4.9M | 9.3M | 4.9M | |
| Other Operating Expenses | 2.8M | 7.0M | 8.3M | 9.7M | 13.4M | 8.3M | |
| Operating Income | (2.7M) | (5.6M) | (8.3M) | (12.6M) | (10.3M) | (10.8M) | |
| Ebit | (2.7M) | (7.0M) | (8.3M) | (10.4M) | (10.0M) | (10.5M) | |
| Research Development | 588.2K | 4.3M | 3.9M | 507.4K | 1.7M | 1.9M | |
| Ebitda | (2.6M) | (1.8M) | (8.3M) | (9.5M) | (8.8M) | (9.3M) | |
| Total Operating Expenses | 2.8M | 7.0M | 8.3M | 8.8M | 11.7M | 7.9M | |
| Income Before Tax | (3.2M) | (8.5M) | (8.3M) | (10.7M) | (10.2M) | (10.7M) | |
| Total Other Income Expense Net | (457.7K) | (1.7M) | 2.9K | 1.9M | 92.2K | 96.9K | |
| Net Income | (3.7M) | (7.0M) | (8.3M) | (10.6M) | (10.2M) | (10.7M) | |
| Income Tax Expense | 550.3K | 2.5M | (27.9K) | 190.7K | 133.0K | 126.3K | |
| Net Interest Income | (457.6K) | (1.1M) | 6.9K | (213.9K) | (82.3K) | (86.4K) | |
| Interest Income | 97.0 | 13.8K | 14.4K | 9.7K | 84.8K | 89.1K | |
| Net Income From Continuing Ops | (3.2M) | (7.1M) | (8.3M) | (10.7M) | (10.2M) | (10.7M) | |
| Net Income Applicable To Common Shares | (3.2M) | (7.0M) | (8.3M) | (10.6M) | (9.6M) | (10.0M) | |
| Minority Interest | 29.2K | 22.9K | 27.9K | 32.8K | 34.2K | 27.3K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.